DNTH icon

Dianthus Therapeutics
DNTH

Overview Fund Activity

72 hedge funds and large institutions have $288M invested in Dianthus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+2
Holders Change %
+2.86%
% of All Funds
1.58%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
25
Reduced
18
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Alkeon Capital Management
Alkeon Capital Management
New York
$5.13M
2
Russell Investments Group
Russell Investments Group
United Kingdom
$631K
3
State Street
State Street
Massachusetts
$3.41M
4
Northern Trust
Northern Trust
Illinois
$2.41M
5
CC
Casdin Capital
New York
$31.3M

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
$30.3M
2
OM
Opaleye Management
Massachusetts
$3.95M
3
Citadel Advisors
Citadel Advisors
Florida
$1.85M
4
LCM
Laurion Capital Management
New York
$987K
5
AG
Artal Group
Luxembourg
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DWA
76
Dorsey Wright & Associates
California
– -$9K -40 Closed
VFA
77
Valeo Financial Advisors
Indiana
– -$7K -31 Closed
1 2 3
4